The Internet of Medical Things (IoMT) is an amalgamation of medical devices and applications that can connect to healthcare information technology systems using networking technologies.
Rapid changes on the market, also fueled by the COVID-19 pandemic on both a hospital and regulatory level, have accelerated the adoption of IoMT technology.
Probingon as an R&D intensive company has now switched from a device-oriented to clinical-grade wearables and diagnostic company for devices at the point-of-care in improving patient outcome with break-through technologies applying a holistic point of view in creating IoMT systems for diagnostics, monitoring, and the improved treatment of patients along the continuum of care.
Commercializing research with innovation leaders and early customers creates in waves a continuous dialogue on the future potential for innovation in healthcare. In the same spirit, Probingon has also the honor to present the project https://lnkd.in/e84hkKT coordinated by our chairman associate professor Robin Augustine. This technology will have a great effect on mind-controlled bio-mechatronic prosthetics and in assisting patients with spinal cord injuries.
Concurrently, commercializing these technologies can lead to several solutions in leveraging IoMT technology to its fullest in improving wearables, diagnostics and monitoring of patients.
Probingon partner in sales, marketing, training, service, and maintenance via medical device distributors and OEM partners. If you are a member of the profession, an OEM or distributor who wishes to receive updates and news, you are welcome to contact us for opting into future newsletters. #research and #innovationinhealthcare with #medicaldevices and #iomt via #bcratos developing cutting edge #braincomputerinterface#medtech technology commercialized via #probingon